Publications
5532 Results
- Journal / Conference
- American Society of Clinical Oncology 15:310(#868)
- Year
- 1996
- Research Committee(s)
- Head and Neck
- Study Number(s)
- SWOG-9305 (CALGB-8984)
Evaluation of topotecan in recurrent or metastatic head and neck cancer. SWOG-9305.
- Journal / Conference
- International Journal of Urology 3:98-100
- Year
- 1996
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8216/38
Local toxicity patterns associated with intravesical bacillus calmette-guerin. A Southwest Oncology Group study.
- Journal / Conference
- Urologic Oncology 2:27-34
- Year
- 1996
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8795 (INT-0094) (EST-1888)
Prognostic significance of DNA ploidy in Ta/T1 bladder cancer: A Southwest Oncology Group study.
- Journal / Conference
- American Society of Clinical Oncology 15:358(#1052)
- Year
- 1996
- Research Committee(s)
- Leukemia
- Study Number(s)
- SWOG-8417/19, SWOG-9030
Comparison of tumor suppressor gene inactivation in de novo and relapsed adult acute lymphoblastic leukemia (ALL).
- Journal / Conference
- American Society of Clinical Oncology 15:411(#1257)
- Year
- 1996
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-8736 (INT-0093)
Three cycles of CHOP (3) plus radiotherapy (RT) is superior to eight cycles of CHOP (8) alone for localized intermediate and high grade non-Hodgkin's lymphoma (NHL): A Southwest Oncology Group study.
- Journal / Conference
- American Society of Clinical Oncology 15:313(#882)
- Year
- 1996
- Research Committee(s)
- Head and Neck
- Study Number(s)
- SWOG-8892 (INT-0099) (EST-2388) (RTOG-8817)
Superiority of chemo-radiotherapy (CT-RT) vs radiotherapy (RT) in patients (pts) with locally advanced nasopharyngeal cancer (NPC). Preliminary results of intergroup (0099) (SWOG8892, RTOG8817, ECOG2388) randomized study.
- Journal / Conference
- American Society of Clinical Oncology 15:211(#486)
- Year
- 1996
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-8899 (INT-0089)
Fluorouracil (FU), leucovorin (LV) and levamisole (LEV) adjuvant therapy for colon cancer: Preliminary results of INT-0089.
- Journal / Conference
- American Society of Clinical Oncology 15:359(#1058)
- Year
- 1996
- Research Committee(s)
- Leukemia
- Study Number(s)
- SWOG-9031
AML in the elderly: Stratification by MDR1 phenotype, secondary vs de novo status, and cytogenetics identifies patients with high complete remission (CR) rates. A Southwest Oncology Group study.
- Journal / Conference
- American Society of Clinical Oncology 15:215(#500)
- Year
- 1996
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-9051
Combined hepatic chemoembolization (CE) and systemic continuous infusion 5-FU (CIFU) + leucovorin (LV) for metastatic colorectal cancer (MCC): A phase II Southwest Oncology Group trial.
- Journal / Conference
- American Society of Clinical Oncology 15:229(#559)
- Year
- 1996
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-9157